Matt Belvedere, a veteran journalist at the intersection of live news and the internet, is editor of the group who mines CNBC's television guests for investment analysis and insight.
Following years of cable and major market live TV news production, Belvedere started in 2007 the award-winning video department at usnews.com, the website of U.S. News & World Report. He also managed online strategies there at a time when the magazine was transitioning to a digital first organization.
Belvedere was nominated for a local Emmy as the producer of morning ratings leader "News4 Today" at WRC, the NBC-owned station in Washington, D.C.
Prior to WRC, he started his career in TV production at CNBC, where he returned in the fall of 2011 as a producer on "Street Signs," before joining the digital team.
— Follow Matt Belvedere on Twitter @Matt_Belvedere
"Mexico has better treaties with the rest of the world than the United States has. We're going to fix that," Wilbur Ross tells CNBC.
On the final day of November, U.S. stock futures were modestly higher, as oil was surging about 7 percent on renewed hopes for an OPEC production cut.
Despite endorsing Clinton and enduring Trump's repeated criticisms, the NYT's paid subscriptions have soared since Election Day.
Media mogul Bob Johnson tells CNBC that Trump wants to work with African-Americans and all Americans.
House Majority Leader Kevin McCarthy tells CNBC he gives Donald Trump credit for even meeting with Mitt Romney.
Despite concerns about waning demand for Apple's iPhone, it is still the must-have holiday gift, tech analyst Gene Munster tells CNBC.
Solanezumab, an experimental drug from Eli Lilly, failed to slow the loss of cognitive ability in patients with mild Alzheimer's disease.
"We've got to manage that. It's part of our new reality," HPE CEO Meg Whitman tells CNBC, after it reported mixed quarterly results.